The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes.

Diabetes Res Clin Pract 2004 Jul;65(1):21-8

Department of Nutrition and Biochemistry, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Objective: The purpose of the present study was to assess the impact of Mg + Zn, Vitamins C + E, and combination of these micronutrients on serum lipid and lipoprotein profiles in type 2 diabetic patients.

Materials And Methods: In a randomized, double-blind, placebo controlled clinical trial, 69 type 2 diabetic patients were randomly divided into four groups, each group receiving one of the following daily supplement for 3 months; group M: 200 mg Mg and 30 mg Zn (n = 16), group V: 200mg Vitamin C and 150 mg Vitamin E (n = 18), group MV: minerals plus vitamins (n = 17), group P: placebo (n = 18). Fasting blood and urine samples were collected at the beginning and at the end of the trial. Serum triglyceride, total cholesterol, high density lipoprotein cholesterol (HDL-c) and low density lipoprotein cholesterol (LDL-c) were measured enzymatically. Apolipoproteins (apo) A1 and B were measured by immunoturbidimetric method. Adjustment for differences in baselines covariates and changes in variables during study were performed by analysis of covariance using general linear models.

Results: Results indicate that after 3 months of supplementation mean serum levels of HDL-c and apo A1 increased significantly in the MV group by 24% (50.4 +/-19.3 mg/dl versus 40.6 +/- 10.8 mg/dl) and 8.8% (169.8 +/- 33.8 mg/dl versus 156.1+ /- 23.9 mg/dl), respectively (P < 0.01). There were no significant changes in the levels of these parameters in the other three groups. Serum levels of total cholesterol, LDL-c, triglyceride, and apo B were not altered after supplementation in all four groups.

Conclusion: It is concluded that since co-supplementation of Mg, Zn, Vitamins C and E significantly increases HDL-c and apo A1, supplementation of these micronutrients could be recommended for the type 2 diabetic patients based on their daily requirements.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diabres.2003.11.009DOI Listing
July 2004

Publication Analysis

Top Keywords

type diabetic
12
diabetic patients
8
mg/dl versus
8
density lipoprotein
8
lipoprotein cholesterol
8
cholesterol ldl-c
8
total cholesterol
8
profiles type
8
serum levels
8
hdl-c apo
8
group
6
changes variables
4
study performed
4
variables study
4
covariates changes
4
differences baselines
4
baselines covariates
4
performed analysis
4
analysis covariance
4
adjustment differences
4

Similar Publications

The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.

J Ren Nutr 2002 Jul;12(3):183-9

Food and Nutrition Services, Charlton Methodist Hospital, Dallas, TX, USA.

Objective: To examine the effect of zinc sulfate supplementation on the concentrations of serum zinc and serum cholesterol in hemodialysis (HD) patients.

Setting: Outpatient dialysis center in a large metropolitan city.

Design: Randomized, double-blind, before-after trial. Read More

View Article and Full-Text PDF
July 2002

The salutary effects of antioxidant vitamins on the plasma lipids of healthy middle aged-to-elderly individuals: a randomized, double-blind, placebo-controlled study.

J Med Liban 2002 Jan-Apr;50(1-2):10-3

Department of Cardiology, Shiraz University of Medical Sciences, Shiraz, Iran.

Study Objective: To determine the efficacy of antioxidant vitamins C and E in lowering the serum lipid levels in apparently healthy middle aged-to-elderly subjects.

Design: Randomized, double-blind, placebo-controlled trial.

Setting: University outpatient clinic. Read More

View Article and Full-Text PDF
October 2003

[The effects of simvastatin combined with different antioxidant vitamin regimens on serum lipid profile in patients with low HDL cholesterol levels].

Anadolu Kardiyol Derg 2004 Dec;4(4):318-22

Department of Cardiology, Medical Faculty, Başkent University, Ankara.

Objective: This study was designed to compare the effects of simvastatin versus a combination of simvastatin with vitamin C or E on serum lipid profile, particularly, high-density lipoprotein (HDL)-cholesterol (C) level, in patients with a low HDL-C level.

Methods: Fifty-nine women and 49 men, who had a baseline HDL-C level equal to or lower than 40 mg/dl were randomized to one of the following study treatment groups: Group S (n=39) simvastatin 20 mg/day, Group S+C (n=33) simvastatin 20 mg/day + vitamin C 500 mg/day, and Group S+E (n=36) simvastatin 20 mg/day + vitamin E 400 IU/day. The groups' lipid profiles were obtained at baseline, 3rd and 6th months. Read More

View Article and Full-Text PDF
December 2004

Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

Clin Ther 2006 May;28(5):679-88

Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.

Background: Although the metabolic effects of the thiazolidinediones have been well studied, there is a lack of comparative data on their effects on certain cardiovascular risk factors, such as elevated plasma levels of lipoprotein (a) (Lp[a]) and homocysteine (Hcy).

Objective: This study compared the effects of pioglitazone or rosiglitazone added to glimepiride on a range of lipid parameters, focusing on Lp(a) and Hcy, in patients with type 2 diabetes mellitus and the metabolic syndrome.

Methods: This was a multicenter, randomized, controlled, double-blind study in patients with type 2 diabetes and the metabolic syndrome (hypertension [>or=130/85 mm Hg]) and triglyceridemia (>or=150 mg/dL). Read More

View Article and Full-Text PDF
May 2006